Evaluates biomarkers for asthma control in children, suggesting potential for clinical application.
Serum CLC and TPSB2 show promise as potential biomarkers for evaluating airway inflammation and predicting asthma control in children; however, their clinical utility remains to be validated in multicenter studies with longer follow-up.
No takes yet. Share an insight, caveat, or question.
Qi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: